119 related articles for article (PubMed ID: 8805647)
1. Probing HLA-B7 conformational shifts induced by peptide-binding groove mutations and bound peptide with anti-HLA monoclonal antibodies.
Smith KD; Mace BE; Valenzuela A; Vigna JL; McCutcheon JA; Barbosa JA; Huczko E; Engelhard VH; Lutz CT
J Immunol; 1996 Sep; 157(6):2470-8. PubMed ID: 8805647
[TBL] [Abstract][Full Text] [Related]
2. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
Vigna JL; Smith KD; Lutz CT
J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
[TBL] [Abstract][Full Text] [Related]
3. Characterization of two Epstein-Barr virus epitopes restricted by HLA-B7.
Hill A; Worth A; Elliott T; Rowland-Jones S; Brooks J; Rickinson A; McMichael A
Eur J Immunol; 1995 Jan; 25(1):18-24. PubMed ID: 7531143
[TBL] [Abstract][Full Text] [Related]
4. In vitro mutagenesis of HLA-B27. Amino acid substitutions at position 67 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substituted side chain.
el-Zaatari FA; Sams KC; Taurog JD
J Immunol; 1990 Feb; 144(4):1512-7. PubMed ID: 1689355
[TBL] [Abstract][Full Text] [Related]
5. Alloreactive monoclonal antibodies select Kd molecules with different peptide profiles.
Noun G; Reboul M; Abastado JP; Jaulin C; Kourilsky P; Pla M
J Immunol; 1996 Sep; 157(6):2455-61. PubMed ID: 8805645
[TBL] [Abstract][Full Text] [Related]
6. Peptide-induced rescue of serologic epitopes on class I MHC molecules.
Solheim JC; Carreno BM; Myers NB; Lee DR; Hansen TH
J Immunol; 1995 Feb; 154(3):1188-97. PubMed ID: 7529793
[TBL] [Abstract][Full Text] [Related]
7. Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long alpha helices.
Smith KD; Lutz CT
J Immunol; 1997 Mar; 158(6):2805-12. PubMed ID: 9058816
[TBL] [Abstract][Full Text] [Related]
8. Use of two predictive algorithms of the world wide web for the identification of tumor-reactive T-cell epitopes.
Lu J; Celis E
Cancer Res; 2000 Sep; 60(18):5223-7. PubMed ID: 11016651
[TBL] [Abstract][Full Text] [Related]
9. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
[TBL] [Abstract][Full Text] [Related]
10. Changes in conformation with loss of alloantigenic determinants of a histocompatibility antigen (HLA-B7) induced by monoclonal antibodies.
Parham P
J Immunol; 1984 Jun; 132(6):2975-83. PubMed ID: 6202768
[TBL] [Abstract][Full Text] [Related]
11. Changes at the floor of the peptide-binding groove induce a strong preference for proline at position 3 of the bound peptide: molecular dynamics simulations of HLA-A*0217.
Toh H; Savoie CJ; Kamikawaji N; Muta S; Sasazuki T; Kuhara S
Biopolymers; 2000 Oct; 54(5):318-27. PubMed ID: 10935972
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins.
Li Y; Li H; Martin R; Mariuzza RA
J Mol Biol; 2000 Nov; 304(2):177-88. PubMed ID: 11080454
[TBL] [Abstract][Full Text] [Related]
13. Peptide-dependent expression of HLA-B7 on antigen processing-deficient T2 cells.
Smith KD; Lutz CT
J Immunol; 1996 May; 156(10):3755-64. PubMed ID: 8621911
[TBL] [Abstract][Full Text] [Related]
14. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules.
Sidney J; Southwood S; del Guercio MF; Grey HM; Chesnut RW; Kubo RT; Sette A
J Immunol; 1996 Oct; 157(8):3480-90. PubMed ID: 8871647
[TBL] [Abstract][Full Text] [Related]
15. HLA-B7 beta-pleated sheet-derived synthetic peptides are immunodominant T-cell epitopes regulating alloresponses.
Freese A; Zavazava N
Blood; 2002 May; 99(9):3286-92. PubMed ID: 11964295
[TBL] [Abstract][Full Text] [Related]
16. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells.
Kurago ZB; Lutz CT; Smith KD; Colonna M
J Immunol; 1998 Feb; 160(4):1573-80. PubMed ID: 9469412
[TBL] [Abstract][Full Text] [Related]
17. Alloreactive cytotoxic T lymphocytes focus on specific major histocompatibility complex-bound peptides.
Smith KD; Huczko E; Engelhard VH; Li YY; Lutz CT
Transplantation; 1997 Jul; 64(2):351-9. PubMed ID: 9256200
[TBL] [Abstract][Full Text] [Related]
18. Cutting edge: HLA-DM-mediated peptide exchange functions normally on MHC class II-peptide complexes that have been weakened by elimination of a conserved hydrogen bond.
Ferrante A; Gorski J
J Immunol; 2010 Feb; 184(3):1153-8. PubMed ID: 20038641
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of two chemically modified peptide epitopes for the class I MHC protein HLA-B*2705.
Jones MA; Hislop AD; Snaith JS
Org Biomol Chem; 2006 Oct; 4(20):3769-77. PubMed ID: 17024283
[TBL] [Abstract][Full Text] [Related]
20. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix.
Lutz CT; Smith KD; Greazel NS; Mace BE; Jensen DA; McCutcheon JA; Goeken NE
J Immunol; 1994 Nov; 153(9):4099-110. PubMed ID: 7523516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
